Other News To Note
Tuesday, August 23, 2011
Santarus Inc., of San Diego, and Depomed Inc., of Menlo Park, Calif., inked a new commercialization deal for Glumetza (metformin hydrochloride extended-release tablets) under which Santarus will assume broad commercial, manufacturing and regulatory responsibilities to replace a promotion agreement signed in July 2008. The new terms call for Santarus to record revenue from Glumetza sales in the U.S., effective Sept. 1.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.